About Us

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

JDD reaches around 13,760 dermatology healthcare professionals and has been recognized as the official partner of the Skin of Color Update (SOCU) and the ODAC Dermatology Aesthetic and Surgical (ODAC) conferences.

The extremely current and practical editorial content of JDD results in high readership and maximum exposure among the dermatology community.

Our Mission is Excellence through Peer Review: To educate physicians, optimize patient outcomes, and disseminate key scientific information.

JDD is published by SanovaWorks.

In the News

Journal of Drugs in Dermatology Publishes Study Showcasing Clinical Improvements with Burt’s Bees’ Sensitive Skin Regimen as Adjunct to Rosacea Prescription Therapy

DURHAM, N.C.–(BUSINESS WIRE)–Burt’s Bees, a leading provider of personal care products committed to natural health and beauty solutions, today announced that the Journal of Drugs in Dermatology has published clinical data supporting the efficacy and tolerability of Burt’s Bees skin care products as an adjunct to rosacea prescription therapy. Abs

Read More

Hormonal Therapies for Women with Acne

Hormonal therapies are helping to broaden therapeutic options for women with acne as dermatologists look for alternatives to antibiotic treatment. Studies suggest oral contraceptive pills and antiandrogen therapies might rival antibiotics in acne treatment efficacy…

Read More

Burt’s Bees Nature-Based Sensitive Skin Care Clinical Results Published in Journal of Drugs in Dermatology

DURHAM, N.C.–(BUSINESS WIRE)–Burt’s Bees®, a leading provider of personal care products committed to natural health and beauty solutions, today announced that the Journal of Drugs in Dermatology (JDD) published clinical data supporting the efficacy of Burt’s Bees nature-based sensitive skin regimen at maintaining healthy skin barrier function.
Read More

Editorial Board

Founder
Perry Robins, MD

Editor-in-Chief
Deborah S. Sarnoff MD